Skip to main content
. 2020 Jul 15;30(7):1095–1112. doi: 10.1007/s00787-020-01602-8

Table 3.

Changes in frequencies of psychiatric disorders with comorbid somatic disorders and pain from T1 to T2

Any psychiatric disorder Anxiety disorders Mood disorders ADHD Other psychiatric disorders
T1 T2 RDa % (95% CI)
p value
T1 T2 RD % (95% CI)
p value
T1 T2 RD % (95% CI)
p value
T1 T2 RD % (95% CI)
p value
T1 T2 RD % (95% CI)
p value
Total (n = 464)
 Comorbid somatic disorder

  n/ndisorderb (%)

  n/ntotalc (%)

81/440 (18.4) 85/335 (25.4) 33/147 (22.5) 59/186 (31.7) 21/99 (21.2) 24/77 (31.2) 31/203 (15.3) 46/192 (24.0) 20/120 (16.7) 27/107 (25.2)
81/464 (17.5) 85/464 (18.3)

0.8 (− 3.8, 5.5)

0.713

33/464 (7.1) 59/464 (12.7)

5.6 (2.0, 9.3)

0.003

21/464 (4.5) 24/464 (5.2)

0.7 (− 2.0, 3.3)

0.612

31/463 (6.7) 46/463 (9.9)

3.2 (− 0.2, 6.7)

0.059

20/464 (4.3) 27/464 (5.8)

1.5 (− 1.3, 4.4)

0.274

 Chronic paind

  n/ndisorder (%)

  n/ntotal (%)

304/438 (69.4) 225/330 (68.2) 108/147 (73.5) 147/185 (79.5) 79/99 (79.8) 71/76 (93.4) 135/202 (66.8) 122/188 (64.9) 74/120 (61.7) 70/106 (66.0)
304/462 (65.8) 225/456 (49.3)

− 16.5 (− 21.0, − 11.0)

 < 0.001

108/463 (23.3) 147/463 (31.8)

8.5 (3.1, 13.7)

0.002

79/464 (17.0) 71/463 (15.3)

− 1.7 (− 5.8, 2.3)

0.400

135/462 (29.2) 122/461 (26.5)

− 2.7 (− 7.2, 2.0)

0.261

74/464 (16.0) 70/463 (15.1)

− 0.9 (− 4.6, 3.3)

0.745

 Multisite paine

  n/ndisorder (%)

  n/ntotal (%)

171/435 (39.3) 141/329 (42.9) 68/145 (46.9) 103/185 (55.7) 56/99 (56.6) 51/76 (67.1) 71/201 (35.3) 67/187 (35.8) 39/120 (32.5) 45/106 (42.5)
171/459 (37.3) 141/455 (31.0)

− 6.3 (− 13.3, − 2.1)

0.008

68/462 (14.7) 103/463 (22.3)

7.6 (3.1, 12.1)

0.001

56/464 (12.1) 51/463 (11.0)

− 1.1 (− 4.7, 2.5)

0.553

71/461 (15.4) 67/462 (14.5)

− 0.9 (− 4.5, 3.1)

0.732

39/464 (8.4) 45/463 (9.7)

1.3 (− 1.7, 4.3)

0.386

Girls (n = 256)
 Comorbid somatic disorder

  n/ndisorder (%)

  n/ntotal (%)

53/245 (21.6) 57/191 (29.8) 24/96 (25.0) 50/143 (35.0) 17/82 (20.7) 22/66 (33.3) 14/83 (16.9) 25/91 (27.5) 11/52 (21.2) 18/50 (36.0)
53/256 (20.7) 57/256 (22.3)

1.6 (− 5.1, 8.2)

0.642

24/256 (9.4) 50/256 (19.5)

10.1 (4.3, 16.1)

0.001

17/256 (6.6) 22/256 (8.6)

2.0 (− 2.3, 6.3)

0.353

14/255 (5.5) 25/255 (9.8)

4.3 (− 0.2, 9.0)

0.056

11/256 (4.3) 18/256 (7.0)

2.7 (− 1.1, 6.8)

0.144

 Chronic pain

  n/ndisorder (%)

  n/ntotal (%)

202/245 (82.5) 158/189 (83.6) 81/96 (84.4) 126/142 (88.7) 69/82 (84.2) 63/65 (96.9) 69/83 (83.1) 74/89 (83.2) 42/52 (80.8) 41/50 (82.0)
202/256 (78.9) 158/254 (62.2)

− 16.7 (− 46.8, − 21.5)

 < 0.001

81/256 (31.6) 126/255 (49.4)

17.8 (9.5, 25.4)

 < 0.001

69/256 (27.0) 63/255 (24.7)

− 2.3 (− 9.0, 4.3)

0.486

69/256 (27.0) 74/255 (29.0)

2.0 (− 3.4, 7.3)

0.466

42/256 (16.4) 41/256 (16.0)

− 0.4 (− 5.9, 5.1)

0.886

 Multisite pain

  n/ndisorder (%)

  n/ntotal (%)

131/243 (53.9) 114/189 (60.3) 56/94 (59.6) 94/142 (66.2) 53/82 (64.6) 47/65 (72.3) 46/83 (55.4) 49/89 (55.1) 23/52 (44.2) 34/50 (68.0)
131/254 (51.6) 114/254 (44.9)

− 6.7 (− 17.6, 0.8)

0.074

56/254 (22.1) 94/255 (36.9)

14.8 (7.7, 22.1)

 < 0.001

53/256 (20.7) 47/255 (18.4)

− 2.3 (− 8.6, 3.9)

0.453

46/256 (18.0) 49/255 (19.2)

1.2 (− 3.9, 7.1)

0.572

23/256 (9.0) 34/256 (13.3)

4.3 (− 0.2, 8.9)

0.055

Boys (n = 208)
 Comorbid somatic disorder

  n/ndisorder (%)

  n/ntotal (%)

28/195 (14.4) 28/144 (19.4) 9/51 (17.6) 9/43 (20.9) 4/17 (23.5) 2/11 (18.2) 17/121 (14.0) 21/101 (20.8) 9/68 (13.2) 9/57 (15.8)
28/208 (13.5) 28/208 (13.5)

0 (− 6.4, 6.4)

1

9/208 (4.3) 9/208 (4.3)

0 (− 4.0, 4.0)

1

4/208 (1.9) 2/208 (1.0)

− 0.9 (− 4.0, 1.8)

0.414

17/208 (8.2) 21/208 (10.1)

1.9 (− 3.5, 7.4)

0.465

9/208 (4.3) 9/208 (4.3)

0 (− 4.3, 4.3)

1

 Chronic pain

  n/ndisorder (%)

  n/ntotal (%)

102/193 (52.9) 67/141 (47.5) 27/51 (52.9) 21/43 (48.8) 10/17 (58.8) 8/11 (72.7) 66/119 (55.5) 48/99 (48.5) 32/68 (47.1) 29/56 (51.8)
102/206 (49.5) 67/202 (33.2)

− 16.3 (− 29.0, − 9.3)

 < 0.001

27/208 (13.0) 21/208 (10.1)

− 2.9 (− 9.1, 3.3)

0.355

10/208 (4.8) 8/208 (3.9)

− 0.9 (− 5.2, 3.2)

0.617

66/206 (32.0) 48/206 (23.3)

− 8.7 (− 16.1, − 0.5)

0.038

32/208 (15.4) 29/207 (14.0)

− 1.4 (− 6.8, 4.9)

0.739

 Multisite pain

  n/ndisorder (%)

  n/ntotal (%)

40/192 (20.8) 27/140 (19.3) 12/51 (23.5) 9/43 (20.9) 3/17 (17.7) 4/11 (36.4) 25/118 (21.2) 18.98 (18.4) 16/68 (23.5) 11/56 (19.6)
40/205 (19.5) 27/201 (13.4)

− 6.1 (− 7.4, − 0.4)

0.029

12/208 (5.8) 9/208 (4.3)

− 1.5 (− 6.0, 3.0)

0.491

3/208 (1.4) 4/208 (1.9)

0.5 (− 2.5, 3.6)

0.705

25/205 (12.2) 18/207 (8.7)

− 3.5 (− 8.7, 1.7)

0.178

16/208 (7.7) 11/207 (5.3)

− 2.4 (− 6.6, 1.5)

0.197

Newcombe confidence intervals and McNemar asymptotic p values are based on paired data displayed in Supplementary Material Table S7

Psychiatric disorder includes both primary and additional diagnoses, based on only complete case (diagnostic assessment at both T1 and T2)

Comorbid somatic disorder includes all patients with somatic disorders that require regular controls

aRD is risk difference, the difference between the proportions of patients with psychiatric disorder or comorbid psychiatric disorder at T2 compared with T1

bn/ndisorder means that there are (n) numbers of patients with comorbid somatic disorder among the patients with the actual psychiatric disorder

cn/ntotal means that there are (n) numbers of patients with comorbid somatic disorder among the total sample of patients

dChronic pain was defined as pain occurring at least once a week in the last 3 months, not related to any known disease or injury

eMultisite pain was defined as having chronic pain in three locations or more